GlaxoSmithKline Dividend yield




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   GBP per share 
 Price  13.07
 Dividend  0.80
 Earnings  0.65
 Cash-flow  1.26
 Book value  0.00
 Equity  0.00

GlaxoSmithKline is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. GlaxoSmithKline is a company from UK, and his stocks are publicly traded.

GlaxoSmithKline paid a total dividend of 3,934 million GBP last year, for a market value of 64,265 millions (Market Cap 63,113 millions). Dividend per share of GlaxoSmithKline is 0.80 GBP, and his stock market price 13.07 GBP.

According to the chart below, where dividend yield is displayed, GlaxoSmithKline has a dividend yield of 6.12%, which is higher than the amount offered by both the market average and companies from UK. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare GlaxoSmithKline dividend yield with other Pharmaceuticals and Biotechnology companies or firms from UK.

Dividend yield of GlaxoSmithKline

GlaxoSmithKline Dividend Payout

About the ability of GlaxoSmithKline to maintain his current dividend of GBP 0.80 per share, an amount that accounts for 6.12%, we should study its payout ratio both on earnings and on cash-flows (see chart below). GlaxoSmithKline payout on ernings is currently 123.08%, which is higher than the market average, and companies of Health Care industry, which are 38.75% and 26.91% respectively. Both figures show that GlaxoSmithKline can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of GlaxoSmithKline is GBP 1.26 per share, which is higher than the dividend per share paid by the company of GBP 0.80, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of GlaxoSmithKline, compared againt world market average, UK companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies. You might also need to check full financial report of GlaxoSmithKline.

GlaxoSmithKline payout

GlaxoSmithKline Stock performance

Finally, last moth GlaxoSmithKline showed a return of -1.00% compared to a worldwide -3.60% average, and a -3.29% of Health Care firms. Over the last year, the company obtained a -20.70% versus a worldwide performance of a 13.88%. More detailed information can be seen in the following graph for UK and Pharmaceuticals and Biotechnology firms.

GlaxoSmithKline stock and market return

Next companies

GlaxoSmithKlinensume. India. Consumer Goods.

Glencore. UK. Basic Materials.

Glenmark Pharmaceuti. India. Health Care.

Global Brands Group. Hong-Kong. Consumer Goods.

Global Logistic Prop. Singapore. Financials.

Global Mediacom Tbk. Indonesia. Consumer Services.

Previous companies

Glanbia. Ireland. Consumer Goods.

GKN. UK. Consumer Goods.

Gjensidige Forsikrin. Norway. Financials.

Givaudan N. Switzerland. Basic Materials.

Gilead Sciences. USA. Health Care.

Giant Manufacturing. Taiwan. Consumer Goods.

 

 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.